Objectives: Despite the inverse association between cigarette smoking and body mass index (BMI), it is unknown whether the effect of smoking on insulin is mediated through decreased BMI. This study aims to examine the temporal relationship between BMI and insulin, the impact of smoking on this relationship and the mediation effect of BMI on the association between smoking and insulin levels.
| INTRODUCTION
Cigarette smoking is one of the leading modifiable risk factors for cardiovascular disease. 1 Smoking increases the risk of cardiovascular disease, among other mechanisms, at least in part through its association with cardiovascular risk factors such as central obesity, hypertension, dyslipidaemia, insulin resistance and type 2 diabetes. [2] [3] [4] [5] [6] [7] [8] There has been convincing evidence that cigarette smoking is associated with lower body mass index (BMI), [8] [9] [10] but with higher prevalence of central obesity. 8, 10, 11 A large epidemiological study of half a million Chinese adults has demonstrated that smoking is significantly associated with lower BMI and a greater waist circumference-to-height ratio after adjusting for BMI. 10 It is well documented that smoking suppresses β-cell secretion. [12] [13] [14] However, the evidence from previous studies is inconsistent regarding the association of smoking with insulin resistance and fasting insulin levels, [5] [6] [7] [8] [14] [15] [16] [17] [18] [19] although it is well known that smoking leads to an increased risk of type 2 diabetes. 6, 7 Ying Li and Tao Zhang contributed equally to this study.
Many studies have reported a strong inter-correlation between obesity and insulin resistance, 20 suggesting that obesity and hyperinsulinaemia could influence each other based on pathophysiological and metabolic mechanisms. 21 Our previous studies have shown the temporal relationship between obesity and hyperinsulinaemia by providing evidence that higher BMI levels precede hyperinsulinaemia during childhood. 22 Observations on the BMI-and insulin-lowering effect of smoking [8] [9] [10] [14] [15] [16] [17] [18] have raised study questions of whether smoking has an impact on the BMI-insulin temporal relationship and whether the observed negative correlation between smoking and insulin is mediated through decreased BMI as the result of smoking.
Using a longitudinal cohort from the Bogalusa Heart Study, the present study aims to examine the temporal sequence between BMI and insulin in adults, the impact of cigarette smoking on the temporal relationship patterns and the mediation effect of BMI on the smoking-insulin association.
2 | METHODS
| Study cohort
The Bogalusa Heart Study is a series of long-term epidemiological studies in a semi-rural, biracial (65% white and 35% black) community 
| Statistical methods
Analyses of covariance were performed using generalized linear models to test differences in continuous study variables between race and gender groups. The effect of smoking on BMI and fasting insulin was examined in linear regression analysis models. The differences in the regression coefficients between race or gender groups were tested in interaction regression models by including smokingrace or smoking-gender interaction terms. Differences in the effect of BMI on insulin between smoking groups were tested in interaction regression models by including smoking-BMI interaction terms.
The study design of longitudinal changes in BMI and insulin, mea- and comparative fit index (CFI). 26 A significant path coefficient (β 1 or β 2 ) suggests the directionality, and a significant difference between β 1 and β 2 suggests a stronger path between the 2 variables measured over time. Stratified analyses were performed to examine the difference in cross-lagged analysis parameters between smoking and nonsmoking groups. The difference between β 1 and β 2 derived from the
Cross-lagged path analysis of BMI and insulin, adjusted for race, age, gender and follow-up years in the total sample. β 1 and β 2 , cross-lagged path coefficients; r 1 , synchronous correlations; r 2 and r 3 , tracking correlations; R 2 , variance explained. Goodness-of-fit: root mean square residual (RMR) = 0.091. Comparative fit index (CFI) = 0.882. Coefficients different from 0: *P < .05, **P < .01, † P < .001 for difference between β 1 and β 2 standardized variables (Z-scores) was tested using Fisher's Z-test as described in our previous studies. Mediation analyses were performed using R package mediation, adjusted for age, race and gender, for baseline and follow-up surveys. Table 1 summarizes mean levels (standard deviation) of study variables at baseline and follow-up by race and gender. The mean levels of continuous variables were compared between race and gender groups, adjusting for age (except age itself ). Although logtransformed insulin was used for subsequent analyses, the original insulin values are presented in Table 1 . BMI and insulin showed significant race differences (black > white) in females and showed opposite trends in gender differences in white (male > female) and black participants (male < female) at baseline and follow-up. Insulin showed significant gender differences in black participants (males < females) at baseline and white participants (male > female) at follow-up. baseline BMI to follow-up insulin (β 2 , 0.273; P < .001) for nonsmokers was significantly greater than that (β 2 , 0.122; P = .046) for smokers, with P = .013 for the difference in β 2 between smokers and non-smokers. Table 2 presents cross-lagged path coefficients in smokers and non-smokers by race and gender groups. The path coefficients (β 2 s) were all significant in subgroups except for female smokers (β 2 , −0.031, P = .719). The differences between β 1 and β 2 in non-smokers were all significant (P < .010), but not in smokers, with the exception of the male group. Differences in β 1 and β 2 between smokers and non-smokers in subgroups were not significant, with the exception of the female group.
| RESULTS
There was a wide range in the number of follow-up years (10.0-25.2) in this study cohort. To examine the possible influence of different follow-up periods, the path coefficients (β 1 and β 2 ) were estimated in 2 subgroups classified by number of follow-up years (10.0-17.4 and 17.5-25.2). β 2 was 0.185 (P < .001) and 0.238 (P < .001) in the 2 subgroups, respectively, with P = .389 for the difference. Table 3 shows the total effects of smoking on age-adjusted BMI and log-insulin presented as standardized regression coefficients at baseline and follow-up in the total sample, and in gender and race Continuous variables are presented as means (SD). *P < .05 and **P < .01 gender difference within race.
a P values were adjusted for age.
b The mean of pack-years of smokers.
groups. The total effects of smoking on BMI and insulin were all significantly negative at baseline and follow-up in the total sample. The total effects of smoking on BMI were all significantly negative in subgroups at baseline and follow-up, with the exception of black participants at baseline and of females. The total effects of smoking on insulin were significantly negative at follow-up for race and gender groups. The race and gender differences in the total effects of smoking on BMI and insulin were not significant except the difference in BMI at follow-up between males (−0.203) and females (−0.066) (P = .027 for the difference). The effects of smoking on insulin, adjusting for BMI, became non-significant at baseline and follow-up in the total sample, and in the race and gender groups, with the exception of black participants at follow-up, and females at baseline and follow-up. The interaction effect of smoking and BMI on insulin was examined in interaction regression models. Standardized regression coefficients (β) were 0.592 in non-smokers and 0.603 in smokers at baseline (P = .811 for interaction), and were 0.587 in nonsmokers and 0.557 in smokers at follow-up (P = .520 for interaction). Total effects of pack-years of smoking on BMI and insulin at baseline and follow-up in the total sample, and in gender and race groups are presented in Table S1 .
Figures 3 and 4 present the mediation effects of BMI on the smoking-insulin association at baseline and follow-up, respectively.
The total effects of smoking on insulin, measured as standardized regression coefficients were −0.073 (P = .015) at baseline and −0.121 (P < .001) at follow-up. The mediation effect of BMI was 53.4%
(P = .030) at baseline and 58.7% (P < .001) at follow-up. The direct effect of smoking on insulin at follow-up (−0.050) was also significant FIGURE 2 Cross-lagged analysis models of BMI and insulin in smoker and non-smoker groups, adjusted for race, age, gender, and follow-up years. β 1 and β 2 , cross-lagged path coefficients; r 1 , synchronous correlations; r 2 and r 3 , tracking correlations; R 2 , variance explained. Goodness-of-fit: root mean square residual (RMR) = 0.091 and Comparative fit index (CFI) = 0.892 for smokers; RMR = 0.091 and CFI = 0.883 for non-smokers. Coefficients different from 0: *P < .05, **P < .01, † P = .013 for difference in β 2 between smokers and non-smokers Abbreviations: CF, comparative fit index; RMR, root mean square residual.
a P value for difference between β 1 and β 2 .
b P value for difference in β 1 and β 2 between smokers and non-smokers within race groups.
c P value for difference in β 1 and β 2 between smokers and non-smokers within gender groups.
(P = .038). The mediation effects of BMI on the association between pack-years of smoking and insulin at baseline and follow-up are presented in Figures S1 and S2 , respectively.
| DISCUSSION
The current study found that smoking was significantly associated with lower levels of insulin and BMI. The study question raised from previous and present observations was whether the negative smoking-insulin association depends on the lowering effect of smoking on BMI. This longitudinal study was designed to address the issue in three steps: (1) to establish the temporal sequence of BMI and insulin; (2) to examine the impact of smoking on the temporal relationship; (3) to determine to what degree BMI mediates the smokinginsulin association. The inference analyses of this study showed that increased BMI antedated elevated insulin levels, and this 1-directional relationship was stronger in non-smokers than in smokers. Based on the BMI-to-insulin direction established, the causal mediation analysis model was constructed. The smoking-insulin association was found to be significantly mediated by decreased BMI as the result of smoking. Although the negative association between smoking and insulin levels has been reported, [14] [15] [16] [17] [18] the mediation effect through BMI in this regard has not been examined in previous studies. The present study dissected the complex relationships among smoking, BMI and insulin by utilizing a powerful statistical approach in a longitudinal cohort from the Bogalusa Heart study. a Smoking defined as 0 = no, 1 = yes.
b P values for race difference in βs.
c P values for gender difference in βs.
d BMI was included in the models for adjustment.
FIGURE 3
Mediation effect of BMI on smoking-insulin association at baseline. *P < .05, **P < .01
It is generally considered that obesity leads to hyperinsulinaemia based on pathophysiological and metabolic mechanisms. 21 On the other hand, numerous studies have shown that insulin treatment results in weight gain in diabetes patients. 27 Previous studies have used traditional longitudinal analysis models with limited success in inferring the temporal sequence of obesity and hyperinsulinaemia in children and adults. 28, 29 Our previous study, using a cross-lagged path analysis model, found that increased BMI at baseline preceded higher insulin levels at follow-up in childhood, with black and white participants showing similar patterns of this 1-directional relationship. 22 The observation from the present study in a longitudinal cohort of middle-aged adults replicated the 1-directional relationship from BMI to insulin noted in our early studies.
The mechanisms that underlie the smoking-related reduced body weight involve multiple neurochemical pathways. The effects of smoking on body weight are mediated by nicotine inhaled from cigarette smoke. Nicotine acutely increases the levels of various neurotransmitters, such as the systemic release of catecholamines, dopamine and serotonin in the brain, and it suppresses appetite, consequently reducing food intake. 30, 31 The mechanisms involved in smoking-associated diabetes and insulin resistance have been documented. 6, 7 However, available evidence is inconsistent regarding the association of smoking with insulin resistance and plasma insulin levels. Some studies have reported that smoking is associated with insulin resistance, [6] [7] [8] 19 and others have shown that smoking is associated with lower insulin levels. [14] [15] [16] [17] [18] It is worthy of note that insulin resistance is determined by 2 components, that is, hyperglycaemia and/or compensatory hyperinsulinaemia. 32 Insulin resistance is not equivalent to high insulin levels by definition. Among others, this may be a reason for the discrepancy in the associations between smoking and these 2 conditions.
It was found in the current study that the 1-directional relationship from BMI to insulin was significantly greater in non-smokers than in smokers. This longitudinal observation suggests that smoking attenuates the correlation between changes in BMI and insulin levels over time, and suppresses the causal relationship from BMI to insulin in smokers. No previous studies have reported the effect of cigarette smoking on the temporal relationship between BMI and insulin levels.
Further research is needed to validate the findings of the present study on the impact of smoking on the time-course sequence of BMI and insulin, and to elucidate the underlying biological mechanisms in this regard.
We found in our earlier report that, among black and white adults from the Bogalusa Heart Study, current smokers had significantly lower insulin levels than those who never smoked. Fasting plasma insulin was significantly lower in current smokers than in those who had never smoked (10.6 vs 13.6 μU/mL, P < .001 for difference). 17 This negative association between smoking and insulin was also observed in large epidemiological studies in other populations. 14, 15 In the current longitudinal study cohort, smoking was significantly and negatively associated with insulin levels at both baseline and follow-up, with black and white participants, as well as males and females, showing the same trends in association. The findings from this and previous studies are consistent with existing evidence that smoking suppresses β-cell function and thus reduces insulin secretion. [12] [13] [14] Given that BMI is highly and positively correlated with insulin levels, a study hypothesis was generated in the current study that smoking results in lower insulin levels through the inverse association between smoking and BMI. The quantitative mediation analyses in this study indicated that the negative smoking-insulin association was significantly mediated by smoking-related decreased BMI, with mediation effects of 53.4% and 58.7% in baseline and follow-up surveys, respectively. The present study provides strong evidence that the inverse association between cigarette smoking and insulin levels involves a significant indirect effect through BMI which is located as a mediator in the pathway from smoking to insulin. In contrast to the nonsignificant direct effect of smoking on insulin at baseline, the longer exposure to cigarette smoke 17 years later at follow-up had a significant direct effect on insulin levels, which supports the notion that smoking reduces β-cell function directly, leading to decreased insulin secretion. [12] [13] [14] This finding suggested that a greater dose of cigarette exposure might have a stronger impact on insulin. The dose-response relationship in the mediation effect of BMI by the dose of cigarette smoke exposure needs to be examined in a larger cohort, which would provide stronger evidence for the impact of smoking on body weight and insulin levels, and on their relationship. The causal mediation model is the simplest form of path analysis. It separates direct and indirect paths in the total effect and quantifies a mediation effect (indirect path). The mediation model has an advantage over a conventional interaction model which specifically detects the difference in the effect of the mediator on the outcome among the predictor groups, smoking groups in this case.
In summary, the current study demonstrates that increased BMI levels precede hyperinsulinaemia in mid-adulthood via longitudinal assessment of their directionality, using a cross-lagged path analysis model. This 1-directional relationship was much stronger in nonsmokers than in smokers. Significant mediation effects of BMI on the association of smoking with insulin were found in both baseline and follow-up surveys. Findings concerning the impact of smoking on the temporal relationship between BMI and insulin, and the significant mediation effects of BMI on the negative smoking-insulin association, would improve our understanding of cigarette smoking-related pathobiology, the mechanisms and natural history of human metabolic disorders, and the development of cardiovascular disease and type 2 diabetes.
FIGURE 4
Mediation effect of BMI on smoking-insulin association at follow-up. *P < 0.05, **P < .01
